BBarclays OOracle · ORCL
Barclays Reiterates Overweight Rating on Oracle (February)
Rating
Buy
Price target
$310
Previous
—
Implied upside
+88%
Barclays analyst Raimo Lenschow reiterated an Overweight rating and $310.00 price target on Oracle (NYSE: ORCL).
“We see ORCL shares higher post the proposed raise of $45-50bn (approx. 1/2 through equity/equity-linked issuances) of gross cash proceeds.
The transactions alleviate pressure for the credit story (incl. maintaining its IG rating) and gives clarity about the financing needs for the year.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
